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ABSTRACT
Neural stem/progenitor cells present in the subventricular
zone (SVZ) are a potential source of repairing cells after
injury. Therefore, the identification of novel players that
modulate neural stem cells differentiation can have a huge
impact in stem cell-based therapies. Herein, we describe a
unique role of histamine in inducing functional neuronal
differentiation from cultured mouse SVZ stem/progenitor
cells. This proneurogenic effect depends on histamine 1
receptor activation and involves epigenetic modifications
and increased expression of Mash1, Dlx2, and Ngn1 genes.
Biocompatible poly (lactic-co-glycolic acid) microparticles,
engineered to release histamine in a controlled and
prolonged manner, also triggered robust neuronal differen-
tiation in vitro. Preconditioning with histamine-loaded
microparticles facilitated neuronal differentiation of
SVZ-GFP cells grafted in hippocampal slices and in in vivo
rodent brain. We propose that neuronal commitment
triggered by histamine per se or released from biomaterial-
derived vehicles may represent a new tool for brain repair
strategies. STEM CELLS 2012;30:773–784
Disclosure of potential conflicts of interest is found at the end of this article.
INTRODUCTION
Neural stem cells reside in two niches of the adult brain: the
subventricular zone (SVZ) lining the lateral ventricles and
the subgranular zone (SGZ) in the dentate gyrus (DG) of the
hippocampus [1]. SVZ-derived neuroblasts migrate through
the rostral migratory stream (RMS) toward the olfactory bulb
where they differentiate into functional interneurons [2].
Interestingly, upon brain injury, some neuroblasts can leave
the RMS to migrate toward damaged areas where they differ-
entiate into the dead cells’ neuronal-specific phenotype [3].
Therefore, taking advantage of these unique stem cell’s
properties, much attention has been given to the design of
experimental strategies for promoting brain repair [4, 5].
For that purpose, it is crucial to identify new proneurogenic
factors that can enhance neural stem cells capabilities.
Histamine, an amine acting as a neurotransmitter and neu-
romodulator at central nervous system (CNS) and peripheral
nervous system, is present in the brain in three main cellular
stores: neuronal, mast, and microglial cells [6]. Its actions can
be mediated through several receptors: two postsynaptic (H1R
and H2R), one presynaptic (H3R), and one more receptor
mainly present in the immune system (H4R). All receptors
belong to the family of rhodopsin-like class A receptors
coupled to guanine nucleotide-binding proteins (G proteins)
[6, 7]. Histaminergic neurons, present in the tuberomammil-
lary nucleus, project numerous ramifications throughout the
entire adult brain. This makes histamine involved in a broad
range of physiological functions, such as sleep-wake control,
emotions, learning, and memory [6–8]. Histamine has
also been reported to be involved in several pathologic condi-
tions, such as neuroinflammation, epilepsy, and brain infarc-
tion [9–11]. Regarding adult neurogenesis, it has been shown
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that histamine receptors are expressed in undifferentiated neu-
ral progenitors. We and others have shown that histamine
transiently increases intracellular free calcium levels ([Ca2þ]i)
in SVZ immature/stem cells, embryonic stem cells, and carci-
noma cells [12, 13]. Moreover, Molina-Hernandez and
Velasco [14] showed that histamine induces embryonic neural
stem proliferation and neuronal differentiation. Despite these
reports, histamine effects on the SVZ neurogenic niche have
not yet been addressed. Herein, we unravel the effects of
histamine in SVZ cell proliferation, survival, and neuronal
differentiation as well as the underlying molecular mecha-
nisms involved. Furthermore, we also developed histamine-
loaded poly (lactic-co-glycolic acid) (PLGA) microparticles in
order to promote a more efficient and controlled delivery of
histamine. Overall, our results identify histamine as a pro-
neurogenic factor for SVZ cells, whose effects are potentiated
through delivery by microparticles, highlighting its possible
use in future brain repair strategies.
MATERIALS AND METHODS
All experiments were performed in accordance with European
Union (86/609/EEC) guidelines for the care and use of labora-
tory animals. Both wild-type (WT) and green fluorescent
protein (GFP) transgenic C57BL6 mice were used.
SVZ Cell Cultures
SVZ cell cultures were prepared from 1 to 3-day-old mice as
described in [15] (Supporting Information). SVZ cells were
grown in serum-free media (SFM) supplemented with 10 ng/ml
epidermal growth factor (EGF) and 5 ng/ml fibroblast growth
factor 2 (FGF-2) (Invitrogen, Carlsbad, CA, http://www.invitro-
gen.com). Six days afterplating, the resulting SVZ neurospheres
were seeded onto glass coverslips coated with 0.1 mg/ml poly-
D-lysine in SFM medium devoid of growth factors. Two days
after plating, the medium was renewed with or without a range
of concentrations for histamine or PLGA histamine-releasing
microparticles.
Pharmacological Treatments
To investigate the influence of histamine on neuronal differen-
tiation, SVZ cells were allowed to develop for 7 days with his-
tamine or histamine-releasing microparticles. Free histamine
(Sigma-Aldrich, St. Louis, MO, http://www.sigmaaldrich.com)
was added to the cell cultures at the following concentrations:
10, 100, and 500 lM. A dilution series of microparticles were
also tested as follows: 10 ng/ml, 100 ng/ml, and 1 lg/ml
(weight of particles per microliter of culture medium).
To determine which histamine receptor was involved in the
proneurogenic effect, SVZ cells were treated with 100 lM his-
tamine together with antagonists for each receptor: mepyramine
(H1R antagonist, 1 lM; Tocris, Bristol, U.K., www.tocris.com),
cimetidine (H2R antagonist, 5 lM; Tocris), or thioperamide
(H3R and H4R antagonist, 1 lM; Sigma-Aldrich). On the
second day, the treatments were renewed. To investigate the
involvement of the c-Jun N-terminal kinase mitogen-activated
protein kinase (JNK MAPK) signaling pathway in response to
histamine stimulation, SVZ neurospheres were exposed to 100
lM histamine for only 6 hours.
To access whether histamine promotes trimethylated lysine
4 form of histone H3 (H3K4m3) on the promoter region of
Mash1, Dlx2, and Neurogenin1 (Ngn1), cells were incubated
with 100 lM histamine for 24 or 48 hours and then processed
for quantitative chromatin immunoprecipitation (qChIP). To
confirm qChIP analysis, the mRNA expression levels of the
aforementioned genes were determined by qRT-PCR in SVZ
cells treated or not (control) with 100 lM histamine for 48 and
72 hours.
Cell-Fate Studies: Sox2 Cell Pair Assay
Dissociated SVZ cell suspensions obtained during the cell cul-
ture procedure were plated onto poly-D-lysine-coated glass cov-
erslips at a density of 6,400 cells per square centimeter. After
seeding, SVZ cells were grown in SFM containing 5 ng/ml
EGF and 2.5 ng/ml FGF-2 (low EGF/FGF-2) supplemented or
not (control) with 100 lM histamine for 24 hours. Cells were
then fixed in methanol for 15 minutes at 20C and processed
for immunocytochemistry against Sox2 and Dlx2.
Preparation and Characterization of PLGA
Microparticles
Single emulsion technique was used to prepare microparticles
of approximately 2 lm in diameter. PLGA (resomer 752H)
(100 mg; Boehringer Mannheim, Mannheim, www.roche.com)
was dissolved in 2.5 ml of a solvent mixture (1:4, methylene
chloride/trifluoroethanol) and 5 mg histamine was added. This
solution was added to a stirred chilled polyvinyl alcohol solu-
tion (100 ml, 5% (w/v)). The resulting suspension was stirred
for 3 hours, washed with distilled water, and finally freeze-
dried. The morphology and diameter of PLGA particles were
evaluated by scanning electron microscopy according to our
previous reports [16]. Release experiments in phosphate-buf-
fered saline (PBS) at 37C were performed in order to evalu-
ate the release profile of histamine for more than 30 days and
to assess the loading efficiency of the microparticles (details
in Supporting Information). Blank microparticles, that is,
without histamine, were also prepared to test the effect of the
microparticle formulation per se in SVZ cells.
Single-Cell Calcium Imaging
To determine the functional differentiation pattern of SVZ cells,
the variations of intracellular calcium concentrations in single
cells following stimulation with 50 mM KCl (Merck, Darmstadt,
Germany, www.merck.com) or 100 lM histamine (Sigma-
Aldrich) were analyzed [13]. Histamine/KCl peak values for
Fura-2 ratio were calculated to determine the extent of neuronal
differentiation in SVZ cultures (Supporting Information).
qChIP
Chromatin was crosslinked to proteins with 1% formaldehyde
and then fragmented by sonication. Chromatin was incubated
overnight with the mouse monoclonal antibody against histone
H3 (trimethyl K4) (H3K4me3; Abcam, ab1012, Cambridge,
U.K., www.abcam.com) or the unrelated antibody as a negative
control (rabbit polyclonal anti-tumor necrosis factor receptor 1
(TNFR1); Santa Cruz Biotechnology, Santa Cruz, CA,
www.scbt.com) and then collected by incubation with protein
G-Sepharose beads (Sigma-Aldrich). DNA eluted from the
washed immune complexes was extracted, precipitated, and
then subjected to quantitative reverse transcription polymerase
chain reaction (qRT-PCR) analysis. Recovery of genomic DNA
as a percentage input was calculated as the copy number ratio
in the precipitated immune complexes to the input control (Sup-
porting Information).
Isolation of Total RNA and Real-Time RT-PCR
Analysis (Mash1, Dlx2, and Ngn1)
Total RNA was isolated from SVZ cells according to illustra
RNAspin mini RNA Isolation Kit manufacturer’s instructions
(GE Healthcare Life Sciences, Hillerød, Denmark, http://
www.gehealthcare.com). The full content of a six-well culture
plate was pooled for each experimental condition. Precipitated
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RNA was resuspended in 40 ll of diethylpyrocarbonate-
treated water, and samples were stored at 80C until further
use. cDNA synthesis was made according to Roche Molecular
Biochemicals transcriptor first strand cDNA synthesis kit
instructions (Roche, Basel, Switzerland, http://www.roche-
appliedscience.com). PCR cycles and primers design are
detailed in Supporting Information.
Organotypic Hippocampal Slice Cultures
Hippocampal slice cultures were prepared from 7-day-old WT
mice as described in [17]. Culture trays were placed in an in-
cubator with 5% CO2 and 95% atmospheric air at 37
C, and
the medium was changed twice a week for 2 weeks. Before
grafting, the medium was replaced with 1 ml of serum-free
neurobasal medium (Invitrogen) containing 1 mM L-glutamine
(Sigma-Aldrich), 2% B27 (Gibco, Invitrogen), 50 U/ml peni-
cillin, and 50 lg/ml streptomycin (Supporting Information).
SVZ-GFP Neurosphere Grafting on Hippocampal
Slices
Histamine-loaded or blank (unloaded) microparticles (both at
1 lg/ml) were added to SVZ neurospheres obtained from GFP
mice 48 hours before grafting. Grafting experiments were done
under sterile conditions with manual delivery of SVZ neuro-
spheres on the surface of hippocampal slices facilitated by a P10
pipette and a blunt Pasteur pipette. In each experimental condi-
tion, one SVZ-GFP neurosphere was grafted on the DG of a hip-
pocampal slice. These cocultures were kept in an incubator for 1
week before fixing with 4% paraformaldehyde (PFA). The whole
hippocampal slice was processed for immunohistochemistry.
In Vivo Transplantation of SVZ-GFP Cells
Histamine-loaded or blank microparticles (1 lg/ml) were added
to GFP-SVZ neurospheres 48 hours before grafting. SVZ neuro-
spheres were dissociated, and the cells were counted and resus-
pended in SFM to a concentration of 50,000 viable cells per
microliter. Weight-matched (generally 25–30 g; 8–9 weeks old)
male WT mice were anesthetized with 2,2,2-tribromoethanol
(Avertin; Sigma-Aldrich) (240 mg/kg, i.p.) and received stereo-
taxic unilateral injections of 2 ll of cell suspension in the right
DG (anteroposterior (AP): 1.9 mm, mediolateral (ML): 1.2
mm, and dorsoventral (DV): 1.8 mm from bregma) or stria-
tum (AP: 0.6 mm, ML: 1.8 mm, and DV: 3.0 mm). After 3
weeks, mice were anesthetized with an overdose of ketamine
(Merial, U.K., http://uk.merial.com) and perfused transcardially
with 4% PFA. Brains were stored overnight at 4C in PFA and
were then transferred to 30% sucrose in PBS at 4C for cryo-
protection. Twenty micrometer coronal sections were cut on a
microtome (Leica Microsystems GmbH, Wetzlar, Germany,
http://www.leica.com) and collected for immunohistochemistry.
Statistical Analysis
Analysis of experiments involving immunocytochemistry and
single-cell calcium imaging (SCCI) was performed in the bor-
der of SVZ neurospheres where migrating cells form a cell
monolayer. Percentages of neuronal nuclear protein (NeuN),
terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL), or bromodeoxyuridine (BrdU) immunoreactive
cells were calculated from cell counts in five independent mi-
croscopic fields (approximately 200 cells per field) in each
coverslip with a 40 objective. These experiments were at
least triplicated, and, within each experiment, experimental
conditions were assayed in two different wells of cultures.
For SCCI experiments, the percentage of neuronal-like
responding cells (histamine/KCl below 0.8) was calculated on
the basis of one microscopic field per coverslip, containing
approximately 100 cells (40 magnification), in a total of at
least three independent cultures where each conditions are
triplicated. Percentages of Sox2 cell pair populations were
obtained from counting approximately 60 cell pairs in
triplicate coverslips obtained from five independent cultures.
Quantification of the number of neuritic ramifications as well
as the total neuritic length positive for phospho-JNK (P-JNK)
per neurosphere was performed in six culture preparations in
approximately 20 nonoverlapping fields per coverslip
(20 magnification). Software used was Axiovision, release
4.6 (Carl Zeiss, G€ottingen, Germany, www.zeiss.com). For
the grafting experiments, the percentage of doublecortin
(DCX)-/GFP-positive cells per total GFP cells was calculated
on the basis of five confocal nonoverlapping fields per hippo-
campal slice, where SVZ-GFP migrating cells emerge from
the core of neurosphere. Each experiment included a series of
control cultures not subjected to any drugs or to blank micro-
particles whenever histamine-loaded microparticles were used.
Data are expressed as mean 6 standard error of the mean
(SEM). Statistical significance was determined by using anal-
ysis of variance (ANOVA) followed by Dunnett’s test or
unpaired two-tailed Student’s t test, with p < .05 considered
to represent statistical significant.
RESULTS
Histamine Promotes Neuronal Differentiation in
SVZ Cell Cultures Via H1R Activation
We have shown that histamine receptors are functional in SVZ
immature cells by means of [Ca2þ]i oscillations driven by H1R
activation [15]. Accordingly, in this work, we show that SVZ
cells express not only histamine receptor 1 (H1R) but also
receptors 2 and 3 (H2R and H3R) mRNA (Supporting Informa-
tion Fig. S1A). To study the effect of histamine on neuronal
differentiation, SVZ cells were treated with histamine for 7
days. Then, to phenotypically evaluate neuronal differentiation,
immunocytochemistry against NeuN, a marker for mature neu-
rons, was performed. As shown in Figure 1A, histamine
increased significantly the percentage of NeuN-positive neurons
when compared with control cultures (control: 6.7% 6 0.8%;
histamine 100 lM: 17.9% 6 2.4%; histamine 500 lM: 21.1%
6 0.6%; p < .001 vs. control). Histamine treatment, however,
had no effect on glial differentiation, as determined by immu-
nostaining and Western blotting against the astrocytic marker
glial fibrillary acidic protein-GFAP (data not shown). We then
analyzed the variations of [Ca2þ]i at single cell level upon KCl
and histamine stimulations, as previously reported by us [15].
The ratio of cellular responses due to histamine or KCl expo-
sure (Hist/KCl) differs significantly between cell types, with a
low Hist/KCl ratio (below 0.8) being characteristic of SVZ-
derived neurons. Therefore, we quantified the percentage of
cells with a low Hist/KCl ratio as a functional measure of neu-
ronal differentiation. As expected, upon histamine treatment,
cells with a neuronal-like response significantly increased when
compared with the control (control: 13.8% 6 3.1%; histamine
100 lM: 35.2% 6 3.9%; histamine 500 lM: 33.4% 6 3.3%; p
< .001 vs. control) (Fig. 1B). A significant shift from a typical
immature profile found in control cultures toward a neuronal-
like profile in 100 lM histamine-treated cultures is shown in
the right panel of Figure 1B.
At all concentrations tested, histamine induced no signifi-
cant changes in cell proliferation and cell death (as assessed
using the BrdU incorporation assay and by TUNEL staining,
respectively; Supporting Information Fig. S1B, S1C). More-
over, we also observed that 100 lM histamine neither alter the
percentage of BrduþKi67þ cells (as a % of total number of
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Ki67þ cells) in differentiation conditions (control: 77.2% 6
2.0%; histamine: 82.9% 6 2.9%; n ¼ 3; data not shown) nor
affected the percentage of cells in G1 (control: 48.1 6 5.9;
histamine: 47.1 6 5.1; n ¼ 5 and 4, respectively), G2 (control:
13.2 6 1.5; histamine: 15.5 6 1.1; n ¼ 5 and 4, respectively),
or S phase (control: 38.8 6 6.5; histamine: 37.4 6 5.1; n ¼ 5
and 4, respectively), as accessed by using a DNA-selective stain
(Vybrant Dye Cycle Orange) in flow cytometry experiments
(proliferative conditions, data not shown). These experiments
reinforce our previous conclusion that histamine does not affect
proliferation of SVZ cells.
Based on this data, we then used 100 lM histamine con-
centration in subsequent experiments. To disclose which re-
ceptor mediates the proneurogenic effect, SVZ cells were
coincubated for 7 days with histamine and the antagonists for
each histamine receptor. Mepyramine (1 lM), an H1R antago-
nist completely abolished the increase of the percentage of
neuronal-like cells induced by histamine (histamine 100 lM
[H100]: 36.4% 6 3.8%; histamine plus mepyramine [H100 þ
Mep]: 22.1% 6 3.9%; p < .01). Neither cimetidine (5 lM),
an H2R antagonist, nor thioperamide (1 lM), a broad antago-
nist of H3R and H4R, was able to block the proneurogenic
effect mediated by histamine (Fig. 1C). These results suggest
that histamine induces functional neuronal differentiation in
SVZ cells via activation of H1R receptor, without affecting
cell proliferation or survival. We also characterized the popu-
lation of GABAergic (vesicular GABA transporter (VGAT)þ
cells) and glutamatergic (vesicular glutamate transporter
Figure 1. Histamine induces neuronal differentiation via H1R activation. (A): Bargram depicts the number of NeuN-positive cells expressed
as percentage of total number of nuclei per culture. Data are expressed as mean percentage of total cells 6 SEM. n ¼ 3–5 coverslips. ***, p <
.001 using Dunnett’s test for comparison with the control. Representative fluorescent photographs of NeuN-positive neurons (green) and Hoechst
33342 staining (blue). Scale bar ¼ 50 lm. (B, C): Bargrams depict the percentages of neuronal-like responding cells as accessed by single cell
calcium imaging (SCCI) analysis; n ¼ 4–12 coverslips. **, p < .01 using Dunnett’s test for comparison with the control. Representative SCCI
response profiles of 20 cells in a control culture and in a culture treated with 100 lM histamine. (C): Bargram depicts the percentages of neuro-
nal-like responding cells. n ¼ 3–11 coverslips. Mep, 1 lM; Cim, 5 lM; Thiop, 1 lM. **, p < .01 and þ, p < .05 using unpaired Student’s t test
for comparison with the control and with 100 lM histamine-treated (H100) cultures, respectively. In all experiments, data are expressed as a
mean 6 SEM. Abbreviations: Cim, cimetidine; Mep, mepyramine; NeuN, neuronal nuclear protein; Thiop, thioperamide.
776 Histamine Stimulates SVZ Neurogenesis
(VGLUT)þ cells) cells in the presence of histamine (Support-
ing Information Fig. S2A, S2B). Indeed, 100 lM histamine
induced an increase in the percentage of VGATþ cells when
compared with untreated controls (control: 16.9% 6 1.6%;
histamine: 29.8% 6 1.2%; p < .001; n ¼ 6), suggesting that
histamine triggers the GABAergic phenotype. In addition, we
observed no effect of histamine treatment on the subpopula-
tion of glutamatergic neurons labeled by VGLUT (control:
19.1% 6 2.6%; histamine: 17.6% 6 1.9%; n ¼ 6).
Histamine Facilitates Epigenetic Modifications and
Subsequent Expression of Proneurogenic Genes
To disclose whether histamine has proneurogenic effects
through histone modifications associated with the transcription
of proneurogenic genes (Mash1, Dlx2, and Ngn1), we then
performed qChIP targeting the H3K4m3 followed by a qPCR
analysis. This specific histone methylation is associated with
the facilitation of proneurogenic genes transcription and there-
fore reflects cell state and lineage potential [18, 19]. As
shown in Figure 2A, SVZ cells exposed to 100 lM histamine,
for 24 hours, showed an approximately 3.5-fold increase in
the association of Mash1 (3.6 6 1.5; n ¼ 5 SVZ cell cultures;
p < .05) and an approximately threefold increase in the asso-
ciation of Dlx2 (3.2 6 0.9; n ¼ 7 SVZ cell cultures; p < .05)
promoters with the trimethylated form of H3K4, when com-
pared with the control cultures. Interestingly, no statistical
increase was seen regarding the association of H3K4Me3 with
the Ngn1 promoter at 24 hours (1.1 6 0.8; n ¼ 5 SVZ cell
cultures). After 48 hours of incubation, the association
of H3K4Me3 to Mash1 (2.0 6 0.6; n ¼ 5 SVZ cell cultures;
p < .05), Dlx2 (2.1 6 0.6; n ¼ 6 SVZ cell cultures; p < .05),
and Ngn1 (3.4 6 1.7; n ¼ 4 SVZ cell cultures; p < .05) pro-
moters was increased, when compared with control (set to 1).
These data suggest that histamine promotes trimethylation of
H3K4 on the promoter regions of the studied proneurogenic
genes with different kinetics and intensities. To confirm that
these epigenetic modifications indeed make DNA more prone
for transcription, we then performed qRT-PCR analysis.
Accordingly, we show that incubating SVZ cells with 100 lM
histamine, for 72 hours, triggered a significant increase in
mRNA levels for Mash1 (1.9 6 0.3; p < .01), Dlx2 (1.8 6 0.3;
p < .001), and Ngn1 (2.9 6 1.0; p < .05), when compared with
controls (set to 1) (Fig. 2B). At 48 hours, no changes were
observed between mRNA levels in controls and 100 lM hista-
mine-treated cultures, confirming that recruitment of H3K4m3
is a previous event that prones the DNA for the subsequent
mRNA transcription of these proneurogenic genes.
Histamine Induces a Shift from Early Immature
Cells Toward Committed Progenitor Cells
Having demonstrated that histamine triggered neuronal differ-
entiation, we further assessed whether histamine induces the
commitment of stem/progenitor cells. Uncommitted stem/pro-
genitor cells divide symmetrically into two stem/progenitor
cells or asymmetrically into a stem/progenitor and a commit-
ted cell, whereas cells committed to differentiate will termi-
nally divide into two progenitor cells. We examined the
capacity of histamine to modify the type of cell division in
freshly isolated single SVZ cells plated for 24 hours with or
without histamine. Sox2 labeling was performed to identify
multipotent neural stem cells with the ability to self-renewal,
whereas committed progenitors were labeled with an anti-
Dlx2 antibody. Cell pairs resulting from the division of single
SVZ stem/progenitor cells were counted. These pairs were
categorized in three groups according to Sox2 expression:
Sox2þ/þ, Sox2þ/, and Sox2/ (Fig. 3A, 3B, 3C, respec-
tively). Histamine at 100 lM induced a significant decrease in
the percentage of Sox2þ/þ cell pairs (control: 45.2% 6
5.1%; histamine: 31.5% 6 2.3%; p < .01) with a concomitant
increase of Sox2/ cell pairs when compared with controls
(control: 30.2% 6 3.1%; histamine: 39.6% 6 3.3%; p < .05)
(Fig. 3D). These data suggest that histamine induced the ter-
minal division of stem/progenitor cells into committed pro-
genitors. Moreover, the reduction of Sox2þ/þ cell pairs upon
treatment suggests that histamine could reduce self-renewal
capacity. Indeed, SVZ neurospheres treated with 100 lM his-
tamine generated lower numbers of secondary neurospheres
(histamine: 86.3% 6 4.1%; control set to 100%; n ¼ 20 SVZ
cell cultures; p < .05; data not shown). These results show
that histamine is actively involved in the reduction of the
immature cells’ pool toward a neural commitment.
Histamine Induces Activation of the JNK MAPK
Pathway on Growing Axons
To evaluate whether histamine promotes neuronal maturation
and axonogenesis, the phosphorylation and subcellular
Figure 2. Histamine promotes the expression of the proneurogenic
genes Mash1, Dlx2, and Ngn1. (A): Bargram depicts the fold increase
of trimethylated lysine 4 form of histone H3 modifications in the pro-
moter regions of Mash1, Dlx2, and Ngn1 genes measured by quantita-
tive chromatin immunoprecipitation analysis. (B): Bargram depicts
the fold increase of mRNA expression for Mash1, Dlx2, and Ngn1
genes measured by quantitative reverse transcription polymerase chain
reaction (qRT-PCR) analysis. Below the graph, representative agarose
gels illustrate the mRNA expression levels of each gene in cultures
under the absence (control, ) or presence of 100 lM histamine for
72 hours (þ). Data are expressed as mean 6 SEM. n ¼ 4–12 subven-
tricular zone cell cultures. *, p < .05; **, p < .01; ***, p < .001
using Dunnett’s test for comparison with control (set to 1). Abbrevia-
tion: Ngn1, Neurogenin1.
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localization of the JNK MAPK pathway were studied. SVZ
cultures exposed to 100 lM histamine, for 6 hours, showed
a robust increase in P-JNK immunoreactivity located in neu-
ritis. In contrast, control cultures showed a faint staining,
with few P-JNK-positive neurites and growth cone struc-
tures. Quantification of the number of ramifications per neu-
rosphere (control: 1.3 6 0.3; 6 coverslips; histamine: 3.5
6 0.5; 6 coverslips; p < .01) as well as the total length of
ramifications and growth cone-like projections positive for
P-JNK per neurosphere (control: 155.5 6 28.3 lm;
Figure 3. Histamine induces a reduction of the Sox2-positive stem-like population and an increase of Sox2-negative progenitor cells. Types of
cell pairs characterized by the expression of Sox2 (red) and Dlx2 (green), namely: (A) two daughter cells (pairs) that coexpress Sox2 and Dlx2
(Sox2þ/þ); (B) two daughter cells that coexpress Dlx2 but just one express Sox2 (Sox2þ/); (C) two daughter cells that only express Dlx2
(Sox2/). Scale bar ¼ 10 lm. (D): Bargram illustrates the effects driven by 100 lM histamine (more than 24 hours) on the fate of newly born
daughter cells by their expression of Sox2 and Dlx2 (Sox2þ/þ, Sox2þ/, and Sox2/). Data are expressed as the percentages of types of cell
pairs per total cell pairs and are represented as mean 6 SEM. n ¼ 5 subventricular zone cell cultures. *, p < .05 and **, p < .01 using Bonferro-
ni’s multiple comparison test for comparison with the respective controls.
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histamine: 315.5 6 40.8 lm; 6 coverslips; p < .05) showed
that 100 lM histamine significantly increased both parame-
ters, compared with control cultures (Fig. 4A). Interestingly,
the P-JNK immunoreactivity induced by histamine was asso-
ciated with Tau, a microtubule-associated protein that pro-
motes bundling and stabilization of axonal microtubules of
both immature and mature neurons (Fig. 4B). All together,
these data suggest that histamine favors axonogenesis and
neuronal maturation.
We may also argue that the JNK MAPK may be involved
in previous events of neurogenesis, such as the initial phases
of cell commitment. Therefore, we performed cell pair experi-
ments, as previously explained, in the presence of 20 lM
SP600125, a specific inhibitor of JNK activity. In fact, we
observed that SP600125 prevented the effects mediated by
histamine on cell commitment, namely, the decrease of the
percentage of Sox2þ/þ (histamine: 27.0% 6 3.9%; histami-
neþSP600125: 45.1% 6 3.9%; p < .05; control: 50.9% 6
2.6%) and the concomitant increase of Sox2/ cell pairs
(histamine: 51.3% 6 2.4%; histamineþSP600125: 25.6% 6
1.7%; p < .001; control: 24.9% 6 1.9%), to levels similar to
untreated cultures (data not shown). Moreover, SP600125 per
se did not alter the levels of any of the categorized groups of
Sox2 cell pairs. Therefore, these results suggest that P-JNK
can be also involved in the initial phases of cell commitment
induced by histamine.
Figure 4. Histamine induces activation of the c-Jun N-terminal kinase, mitogen-activated protein kinase (JNK MAPK) pathway on growing axons.
(A): Representative fluorescent confocal digital images of the phospho-JNK (P-JNK) (green) and Hoechst staining (blue), in control cultures and in
cultures exposed for 6 hours to 100 lM histamine. Arrow depicts P-JNK immunoreactivity in neurites. Scale bar ¼ 20 lm. Bargrams depict numbers
of ramifications and total length (lm) of the P-JNK-positive ramifications per neurosphere. n ¼ 6 culture preparations. **, p < .01 using unpaired
Student’s t test for comparison with the control. (B): Representative fluorescent confocal digital images of P-JNK (green), Tau (red), and Hoechst
33342 (blue) in cultures exposed for 6 hours to 100 lM histamine. Scale bar ¼ 20 lm. Arrows depict axons double labeled for P-JNK and Tau.
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Figure 5. Histamine released from microparticles induces neuronal differentiation in vitro. (A): Characterization of poly (lactic-co-glycolic
acid) microparticles. Left: Scanning electron micrographs of microparticles obtained by single emulsion. Right: Histamine-release profile from
microparticles in phosphate-buffered saline (PBS) aqueous solution at 37C. (B): Distribution of histamine-releasing microparticles in subventric-
ular zone (SVZ) cell cultures. Representative confocal photos of SVZ cells incubated for 1 hour in the presence of 1 lg/ml (right) and 10 lg/ml
(left) histamine-releasing microparticles (fluorescein isothiocyanate (FICT) labeling-green). Cell nuclei were stained with Hoechst 33342 (blue).
Arrows point to microparticles. Scale bars ¼ 20 lm. (C): Left: Bar graph represents number of NeuN-positive cells expressed as percentages of
total number of cells per culture. n ¼ 5–6 coverslips. **, p < .01 using Dunnett’s test for comparison with the control. Right: Representative
confocal digital images of NeuN-positive neurons (red) and Hoechst staining (blue). Scale bar ¼ 20 lm. (D): Left: Bargram depicts the percen-
tages of neuronal-like responding cells analyzed by single cell calcium imaging (SSCI). n ¼ 5–6 coverslips. **, p < .01 using unpaired Student’s
t test for comparison with the control. Right: Representative SCCI profiles of response of 20 cells in a blank or histamine microparticle-treated
cultures. In all experiments, data are expressed as mean 6 SEM. Abbreviation: NeuN, neuronal nuclear protein.
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Histamine Released from PLGA Microparticles
Induces Neuronal Differentiation in SVZ Cell
Cultures
To provide a more efficient and controlled delivery of hista-
mine in the SVZ neurogenic niche, PLGA microparticles
were prepared. These microparticles have an average diameter
of 2 lm (Fig. 5A) and a loading capacity of approximately
5.3 lg of histamine per mg of microparticles. When suspended
in PBS aqueous solution (pH 7.4), they release histamine over a
period of 30 days (Supporting Information Methods; Fig. 5A).
Furthermore, blank (unloaded) or histamine-loaded micropar-
ticles (up to 1 lg/ml of microparticles) incubated with SVZ
cells have no effect on cell viability or proliferation (Supporting
Information Fig. S1D, S1E), and they distribute homogeneously
at the cells’ membrane (Fig. 5B).
A significant increase in the percentage of NeuN-positive
cells was observed in SVZ cells incubated with histamine-
loaded microparticles (1 lg/ml) for 7 days (control: 5.73% 6
0.34%; histamine-loaded microparticles [1 lg/ml]: 13.51% 6
2.38%; p < .01) (Fig. 5C), as evaluated by immunofluores-
cence. In addition, the treated cells show a significant increase
in the percentage of neuronal-like cells (Hist/KCl ratio below
0.8) when compared with blank (unloaded) microparticle-
treated cultures (histamine-loaded microparticles [1 lg/ml]:
36.6% 6 3.2%; blank microparticles [1 lg/ml]: 15.6% 6
2.1%; p < .01). In fact, a neuronal-like profile of [Ca2þ]i was
also observed in histamine microparticle-treated cultures
(Fig. 5D). It should be noted that histamine-releasing micro-
particles did not affect astrocytic differentiation, as detected
by Western blotting against GFAP (data not shown). Overall,
our data suggest that histamine released from PLGA micro-
particles induces a robust neuronal differentiation without
affecting cell viability or proliferation.
Histamine Microparticle-Induced Neuronal
Differentiation of Grafted SVZ-GFP Cells
To further dissect the role of histamine on neurogenesis, an
ex vivo model was developed by grafting SVZ neurospheres
(obtained from GFP transgenic mice, previously treated with
histamine-loaded microparticles for 48 hours) on the DG of
WT organotypic hippocampal slice cultures. After 1 week,
cultures were fixed and immunostained for DCX, a marker
for neuroblasts. As shown in Figure 6A, 6B, 1 lg/ml of hista-
mine-loaded microparticles promoted a robust increase in
DCX-/GFP-positive cells per total GFP cells from 4% to 13%
(blank microparticles: 4.0% 6 0.8%, 2,077 cells counted; his-
tamine-loaded microparticles: 12.9% 6 1.9%, 1,754 cells
counted; p < .001). New neurons (DCXþ/GFPþ) derived
from the SVZ-GFP neurospheres pretreated with histamine-
releasing microparticles showed a complex morphology with
spines, similar to the structure of endogenous granule neurons
present in the host DG (Fig. 6C). Therefore, the SVZ-GFP-
transplanted cells in the hippocampal slice survive and differ-
entiate into new neurons. A similar approach was used in
vivo, grafting SVZ-GFP cells into the hippocampal DG or
striatum of WT mice. Three weeks after transplantation, some
SVZ-GFP cells pre-exposed to histamine-loaded micropar-
ticles integrated the DG and striatum and differentiated into
DCX-positive neuroblasts (Fig. 6D).
DISCUSSION
Since the discovery that classic antihistamines have a sedative
action, it has become clear that histamine affects the CNS.
Figure 6. Histamine microparticles induce neuronal differentiation of
subventricular zone (SVZ)-GFP cells grafted on the DG of hippocampal
slices and in vivo. (A): Representative confocal digital images of DCX
(red), SVZ-GFP cells (green), and Hoechst (blue) in organotypic hippo-
campal slices transplanted with SVZ-GFP cells previously treated for 48
hours with 1 lg/ml histamine-releasing or blank microparticles. Arrows
depict DCX and GFP double-labeled cells. (B): Bar graph represents the
percentage of DCXþ/GFPþ cells per SVZ GFP total cells counted in
hippocampal slices. Data are expressed as mean 6 SEM. n ¼ 6–15
hippocampal preparations. ***, p < .001 using Dunnett’s test for com-
parison with blank-treated cultures. (C): Representative confocal digital
images of DCX-positive neurons (red), SVZ-GFP-transplanted cells
(green), and Hoechst staining (blue) in hippocampal slices transplanted
with SVZ-GFP cells pretreated with 1 lg/ml histamine-releasing micro-
particles. Fluorescent picture at the right side consists in a cropped
image from the limited field in the left figure. Scale bar ¼ 20 lm. (D):
Representative fluorescent confocal digital images of DCX-positive neu-
rons (red), GFP (green), and Hoechst (blue) observed in the grafting site
of the DG and striatum of the WT mouse in vivo. SVZ-GFP cells were
pretreated with 1 lg/ml histamine-releasing microparticles for 48 hours
and then intracerebrally injected in different regions of the mouse brain
for 3 weeks. Scale bar ¼ 20 lm. Abbreviations: DCX, doublecortin;
DG, dentate gyrus; GFP, green fluorescent protein.
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Surprisingly, the putative effects of histamine on postnatal
neurogenesis are still unknown.
We previously showed that immature nestin-positive cells,
coexpressing or not GFAP, can be distinguished on the basis
of the selective increase of [Ca2þ]i in response to histamine
via H1R activation [13]. Indeed, it was also shown by others
that embryonic stem and carcinoma cells express functional
H1R, suggesting a role for this receptor as a marker for undif-
ferentiated neural progenitors [12]. Herein, we found that his-
tamine induces functional neuronal differentiation in SVZ cell
cultures via H1R activation. Moreover, we showed that in
vitro, postnatal SVZ cells retain the potential to differentiate
in GABAergic and glutamatergic neurons, and that GABAer-
gic differentiation is favored by histamine treatment. In fact,
Molina-Hernandez and Velasco [14] showed that histamine
induces an increase in neuronal differentiation and a decrease
in astrocytic cell proportion in neuroepithelial stem cells
derived from the embryonic rat cerebral cortex in vitro. How-
ever, in our case, neuronal differentiation was not occurring
at the expense of glial differentiation since GFAP protein lev-
els were not altered. Moreover, this proneurogenic effect
occurred without affecting proliferation or cell viability. It has
been reported by others that histamine may promote cell pro-
liferation of embryonic stem cells as well as cancer stem cells
[14, 20]. In opposite, Medina et al. [21] showed that hista-
mine impairs proliferation on human malignant melanoma
cells, probably by increasing hydrogen peroxide levels. These
contradictory effects may rely on the specificities displayed
by each cell types (embryonic stem/progenitor cells vs. neona-
tal SVZ stem/progenitor cells vs. cancer stem cells).
Emerging information indicates that epigenetic modifica-
tions comprising histone modifications and chromatin remod-
eling may be inherent to the differentiation of neural stem
cells. Recent studies indicate that lineage control genes such
as Mash1, Dlx2, and Ngn1 are epigenetically modified with a
unique combination of activating histone modifications that
prime them for potential activation upon cell lineage induc-
tion and differentiation [22]. Thus, we then investigated
whether histamine may promote H3K4m3 recruitment to the
promoter of genes involved in neuronal cell fate lineage and
consequently prompt their transcription. Our results suggest
that histamine induced the trimethylation of H3K4 on Mash1,
Dlx2, and Ngn1 promoters that ultimately leads to increased
mRNA expression of the former proneurogenic genes. In fact,
Lim et al. [23] showed that mixed-lineage leukemia 1 is
required for neurogenesis in the mouse postnatal brain by epi-
genetic modulation of the expression of the proneurogenic
gene Dlx2. They showed that in differentiating WT SVZ cells,
Mash1, Olig2, and Dlx2 loci have high levels of H3K4me3,
consistent with their transcription. Mash1 (Ascl1) is a key
transcription factor essential during embryogenesis, being
involved in the production and commitment of neural precur-
sor cells while inhibiting their astrocyte potential [24, 25].
Ngn1 was described to be induced in neuronal precursor cells
and therefore essential for neurogenesis [26]. In accordance,
Wu et al. [27] showed that the expression of Ngn1 increases
drastically in retinoic acid-induced neuronal differentiation of
P19 cell lines. All these reports strength the conclusion that
histamine signaling triggers favorable histone modifications
for the transcription of proneurogenic genes in SVZ cells.
Moreover, we found that histamine induces terminal division
of stem/progenitor cells into committed Sox2/ progenitors
and decreases self-renewal capacity of SVZ cells without
affecting cell proliferation. In line with our results, it has
been shown by others that the neuropeptide Y (NPY) pro-
motes proliferation in SVZ cell cultures; however, NPY is not
inducing an increase in the number of secondary neurospheres
[28]. Moreover, the hepatocyte growth factor has a positive
impact on self-renewal, increasing the number of secondary
neurospheres, but does not have any effect on cell prolifera-
tion [29]. Accordingly, these data show that histamine reduces
stemness in SVZ cells, promoting late precursors pool expan-
sion and neuronal differentiation.
Another key process during neuronal differentiation and
maturation is neurite outgrowth and axon formation. Previ-
ously, we showed that tumor necrosis factor (TNF)-a and
NPY induce axonal formation and maturation in SVZ cells by
activating the JNK MAPK pathway [15, 30]. This pathway is
involved in axonal sprouting and neurite outgrowth but not in
dendritic growth [31]. Therefore, JNK may mediate axonal
outgrowth, microtubule dynamics, and neuronal polarization
by DCX or MAP-2 phosphorylation [32, 33]. Our P-JNK
immunolabelings pointed to an increase in the active form of
this kinase upon histamine treatment. Not only just the num-
ber of ramifications per neurophere but also the total length
of these ramifications was significantly higher in histamine-
treated cultures. The association of this increased labeling
with Tau suggests that histamine might be involved in the
axonal formation of SVZ cells.
Moreover, we showed that histamine-stimulated JNK
activation can be also involved in the initial phases of cell
commitment. This is in line with previous reports showing
that this pathway is involved in neural differentiation from
embryonic stem cells [34].
For a potential delivery of proneurogenic drugs into neu-
rogenic niches, we developed biocompatible PLGA micropar-
ticles that release histamine in a controlled way. PLGA is a
Food and Drug Administration approved copolymer for thera-
peutic devices and extensively investigated for the preparation
of drug delivery formulations [35–37]. It is degradable in
aqueous solutions into lactic and glycolic acid, by-products of
metabolic pathways. Microparticles with an average diameter
of 2 lm were selected to prevent their cellular uptake and
consequently to release histamine at the extracellular millieu.
The histamine released by the microparticles had no effect on
cell proliferation or death, neither the microparticle formula-
tion was toxic per se. Thus, PLGA microparticles are suitable
biocompatible carriers for histamine release on SVZ cell cul-
tures. Not only histamine-releasing microparticles induced a
robust neuronal differentiation from SVZ cell cultures but
also facilitated neuronal differentiation of SVZ-GFP neuro-
spheres grafted in ex vivo or in vivo. Importantly, the real
histamine cumulative released from microparticles was far
smaller (1,000 less) than the initial histamine concentrations
tested for the single-pulse experiments (100 lM). Several
studies reported that in physiologic conditions histamine is
present at nanomolar concentrations in the cerebrospinal fluid
and brain parenchyma of humans and rodents [38–44].
Importantly, circulating levels of histamine and histaminergic
innervations are increased following brain injury and degener-
ation or infection [39, 45-49]. Histamine may therefore have
an important role modulating injury-induced neurogenesis
since it is part of the repertoire of soluble factors released in
the lesioned microenvironment. This suggests that the concen-
tration of 100 lM used in our work is of robust pathophysio-
logical relevance.
In this context, biocompatible histamine-PLGA micropar-
ticles represent an advantage in histamine delivery since this
amine is released in a continuous manner and in concentra-
tions that are closer to physiological levels at the SVZ neuro-
genic niche. In addition, the histamine released by these
microparticles had comparable effects to the ones observed
with single-pulse histamine treatments. This is likely due to
the spatio-temporal controlled delivery of histamine to the
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cells. Microparticles tend to locate at the proximity of cell
membrane, creating a concentration gradient of histamine.
Therefore, low amounts of histamine are required to exert the
same biological effect. Similar results have been obtained pre-
viously by one of us in the vascular differentiation of human
embryoid bodies [50]. The incorporation of polymeric biode-
gradable particles loaded with specific growth factors into
human embryoid bodies had a minimal effect on cell viability
and proliferation but a great impact on vascular differentia-
tion. Therefore, microparticles constitute a novel approach to
promote brain repair by local and continuous delivery of his-
tamine into neurogenic niches.
Our ex vivo data showed that the pre-exposure of SVZ-
GFP cells with histamine microparticles increased neuronal
differentiation of grafted cells in the DG of hippocampal sli-
ces. These data support the concept that pretreatment of neu-
ral stem cells with known proneurogenic factors favors neuro-
nal differentiation of transplanted cells. In vivo, a comparable
approach showed a more discrete but still positive effect on
survival, integration, and differentiation of the pretreated
transplanted cells into the host hippocampus and striatum.
Previous studies have shown that in the intact adult rodent
brain, expanded SVZ cells in vitro preferentially produce neu-
rons upon transplantations in homotypic (SVZ) and hetero-
typic (SGZ) neurogenic niches, whereas upon transplantation
in non-neurogenic regions such as the cortex or the striatum,
SVZ cells generate mainly glial cells [51, 52]. These trans-
plantation approaches indicate that the neuronal phenotype
determination is tightly regulated by local signals derived
from both the SVZ and SGZ neurogenic niches.
CONCLUSION
As a proof of principle, we showed that SVZ-GFP cells pre-
treated with histamine microparticles differentiate into new
neurons at both neurogenic (DG) and non-neurogenic (stria-
tum) niches. Taken together, these results suggest that hista-
mine either added in a one-pulse way or released by a PLGA
microparticle drug delivery systems induces neuronal differen-
tiation in SVZ stem/progenitor cells highlighting its use in
brain repair strategies.
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